Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA)

Background: The coronavirus disease 2019 (COVID-19) pandemic is currently ongoing, and there have been significant efforts in the development of COVID-19 vaccines. However, the neutralizing antibody titers in vaccinated individuals are reported to progressively decrease over time. Japanese pharmaceu...

Descripción completa

Detalles Bibliográficos
Autores principales: Terayama, Yuriko, Tomita, Noriko, Terada-Hirashima, Junko, Uemura, Yukari, Shimizu, Yosuke, Takeuchi, Junko S., Takamatsu, Yuki, Maeda, Kenji, Mikami, Ayako, Ujiie, Mugen, Sugiura, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322091/
https://www.ncbi.nlm.nih.gov/pubmed/35888056
http://dx.doi.org/10.3390/life12070966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322091/
https://www.ncbi.nlm.nih.gov/pubmed/35888056
http://dx.doi.org/10.3390/life12070966

Ejemplares similares